Captopril Treatment in Rheumatic Heart Disease with Congestive Heart Failure A Preliminary Report
A small scale controlled trial of captopril (ACE inhibitor) was conducted in 8 children with congestive heart failure due to rheumatic mitral regurgitation with or without mild mitral stenosis. The age of the patient ranged from 5.5 to 13 years (mean 9,3 years). Four children, served as control group, received digitalis and diuretics as standard treatment; while the other 4 children also received 2 x 12,5 mg of captopril in addition to standard treatment. The effect of both regimens were measured by using
changes of left ventricular function as seen on the echocardiogram performed before treatment, and then 3, 7 and 14 days thereafter.
Definite conclusion cannot be made because of the small number of patients; but it is apparent that some improvements of left ventricular functions in the captopril group were more evident when compared with that of the control group of standard treatment.
Side effects of captopri/ were not found.
2. FEIGENBAUM, H.: Echocardiographic examination of the left ventricle. Circulation 51 : 1-6 (1975).
3. FEIGENBAUM, H.: Echocardiography; 3rd ed., pp. 119-159. (Lea & Febiger, Philadelphia 1981).
4. FRIEDMAN, W.F., GEORGE, B.L.: Treatment of congestive heart failure by altering loading condition of the heart. J. Pediat. 106 : 697 (1985).
5. MASON, E.T.: Introduction to recent advances in pathogenesis and management of congestive heart failure; in Mason, D.T., Ed. Congestive Heart Failure; pp. 1-9, (Yorke, New York, Philadelphia 1976)
6. MEYER, R.A.: Pediatric Echocardiography; pp. 257-79, (Lea & Febiger 1977).
7. MEYER, R.A., STOCKERT, J., KAPLAN, S. : Echocardiographic determination of left ventricular volume in paediatric patients. Circulation 51 : 297-303 (1975).
8. ROELANDT, J.: Practical Echocardiology, pp. 117-28 (Research Studies Press Inc. Forest Grove, Ore 1977).
9. SQUIBB, Capoten-Captopril tablets monograph; pp. 8-9, 54-64 (Er Squibb & Sons Inc. Princeton 1986).
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.